tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IPHA Stock Latest News

Innate Pharma: Navigating Challenges with Promising Pipeline and Strategic Partnerships
RatingsInnate Pharma: Navigating Challenges with Promising Pipeline and Strategic Partnerships
11d ago
IPHA
Innate Pharma price target lowered to $11 from $11.50 at H.C. Wainwright
PremiumThe Fly
Innate Pharma price target lowered to $11 from $11.50 at H.C. Wainwright
12d ago
IPHA
Innate Pharma announces EUR 15M capital increase from Sanofi
PremiumThe Fly
Innate Pharma announces EUR 15M capital increase from Sanofi
12d ago
SNY
IPHA
Innate Pharma regains rights to Anket, announces potential Sanofi investment
PremiumThe Fly
Innate Pharma regains rights to Anket, announces potential Sanofi investment
13d ago
SNY
IPHA
Innate Pharma: Promising Pipeline and Strategic Developments Drive Buy Rating
PremiumRatings
Innate Pharma: Promising Pipeline and Strategic Developments Drive Buy Rating
1M ago
IPHA
Innate Pharma Reports 2024 Financial Results and Clinical Progress
PremiumCompany AnnouncementsInnate Pharma Reports 2024 Financial Results and Clinical Progress
1M ago
IPHA
Buy Rating for Innate Pharma: Lacutamab’s Breakthrough Designation and Market Potential Drive Positive Outlook
Premium
Ratings
Buy Rating for Innate Pharma: Lacutamab’s Breakthrough Designation and Market Potential Drive Positive Outlook
3M ago
IPHA
Innovative Potential of Innate Pharma’s IPH4502 in Overcoming Drug Resistance and Expanding Therapeutic Impact
Premium
Ratings
Innovative Potential of Innate Pharma’s IPH4502 in Overcoming Drug Resistance and Expanding Therapeutic Impact
3M ago
IPHA
Innate Pharma doses first patient in IPH4502 study
PremiumThe Fly
Innate Pharma doses first patient in IPH4502 study
3M ago
IPHA
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
VIR
BCYC
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
KOD
AGIO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
KOD
AGIO
Innate Pharma announces new data from TELLOMAK study
PremiumThe FlyInnate Pharma announces new data from TELLOMAK study
5M ago
IPHA
Innate Pharma partners with IFLI to study IPH6501, to receive $3M upfront
Premium
The Fly
Innate Pharma partners with IFLI to study IPH6501, to receive $3M upfront
5M ago
IPHA
Innate Pharma publishes IPH6501 data in Science Immunology
Premium
The Fly
Innate Pharma publishes IPH6501 data in Science Immunology
6M ago
IPHA
Innate Pharma appoints Jonathan Dickinson as CEO
PremiumThe Fly
Innate Pharma appoints Jonathan Dickinson as CEO
7M ago
INCY
IPHA
Innate Pharma announces FDA clearance of IPH4502 IND
PremiumThe Fly
Innate Pharma announces FDA clearance of IPH4502 IND
8M ago
IPHA
Innate Pharma reports AstraZeneca presentation of results from NeoCOAST-2 study
PremiumThe Fly
Innate Pharma reports AstraZeneca presentation of results from NeoCOAST-2 study
8M ago
AZN
IPHA
Innate Pharma announces updated results from SAR443579/IPH6101
PremiumThe Fly
Innate Pharma announces updated results from SAR443579/IPH6101
11M ago
SNY
IPHA
Innate Pharma announces results from TELLOMAK study
PremiumThe FlyInnate Pharma announces results from TELLOMAK study
11M ago
IPHA
Innate Pharma provides clarification regarding SAR443579 designation
Premium
The Fly
Innate Pharma provides clarification regarding SAR443579 designation
12M ago
SNY
IPHA
Innate Pharma doses first patient in Sanofi-sponsored trial of SAR443579
Premium
The Fly
Innate Pharma doses first patient in Sanofi-sponsored trial of SAR443579
1y ago
IPHA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >